Becton, Dickinson and PT Raised to $115.00 (BDX)
Equities research analysts at Barclays increased their price target on shares of Becton, Dickinson and (NYSE:BDX) from $112.00 to $115.00 in a research note issued on Monday. The firm currently has an “underweight” rating on the stock. Barclays’ price objective would indicate a potential downside of 3.85% from the company’s current price.
Becton, Dickinson and (NYSE:BDX) traded down 0.73% during mid-day trading on Monday, hitting $118.73. 109,217 shares of the company’s stock traded hands. Becton, Dickinson and has a one year low of $96.73 and a one year high of $120.66. The stock has a 50-day moving average of $117.8 and a 200-day moving average of $113.7. The company has a market cap of $22.939 billion and a price-to-earnings ratio of 24.95.
Becton, Dickinson and (NYSE:BDX) last issued its quarterly earnings data on Thursday, May 1st. The company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.50 by $0.05. The company had revenue of $2.07 billion for the quarter, compared to the consensus estimate of $2.09 billion. During the same quarter in the previous year, the company posted $1.39 earnings per share. The company’s quarterly revenue was up 3.6% on a year-over-year basis. On average, analysts predict that Becton, Dickinson and will post $6.25 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Monday, June 30th. Investors of record on Monday, June 9th will be given a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date of this dividend is Thursday, June 5th.
A number of other firms have also recently commented on BDX. Analysts at Zacks reiterated a “neutral” rating on shares of Becton, Dickinson and in a research note on Friday. They now have a $126.00 price target on the stock. Separately, analysts at SunTrust raised their price target on shares of Becton, Dickinson and from $128.00 to $138.00 in a research note on Monday, June 9th. They now have a “buy” rating on the stock. Finally, analysts at RBC Capital raised their price target on shares of Becton, Dickinson and from $109.00 to $113.00 in a research note on Friday, May 9th. They now have a “sector perform” rating on the stock. One research analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $110.31.
Becton Dickinson and Co is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.